CLOBAZAM

CLOBAZAM was reported 17678 times

CLOBAZAM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AUTOMATISM EPILEPTIC 17 0.4722
1 EPILEPSY WITH MYOCLONIC-ATONIC SEIZURES 12 0.4286
2 MITOCHONDRIAL DNA MUTATION 34 0.3953
3 SEVERE MYOCLONIC EPILEPSY OF INFANCY 12 0.3871
4 EPILEPSIA PARTIALIS CONTINUA 15 0.3571
5 ANORECTAL MALFORMATION 17 0.3036
6 ATONIC SEIZURES 224 0.2608
7 BRAIN LOBECTOMY 14 0.2373
8 NEW ONSET REFRACTORY STATUS EPILEPTICUS 23 0.2091
9 ANGIOFIBROMA 15 0.2027
10 SEIZURE CLUSTER 162 0.1954
11 MULTIPLE-DRUG RESISTANCE 599 0.1930
12 VAGAL NERVE STIMULATOR IMPLANTATION 59 0.1928
13 VICTIM OF CHILD ABUSE 48 0.1912
14 EPILEPTIC ENCEPHALOPATHY 42 0.1883
15 CHANGE IN SEIZURE PRESENTATION 114 0.1762
16 DRUG WITHDRAWAL CONVULSIONS 312 0.1753
17 CHILD ABUSE 45 0.1737
18 ASTEATOSIS 20 0.1695
19 CSF OLIGOCLONAL BAND PRESENT 22 0.1692
20 COMA BLISTER 15 0.1667
21 HAEMATURIA TRAUMATIC 11 0.1642
22 EPIDURAL LIPOMATOSIS 55 0.1599
23 LENNOX-GASTAUT SYNDROME 36 0.1586
24 DEVELOPMENTAL REGRESSION 20 0.1471
25 POSTICTAL PSYCHOSIS 22 0.1410
26 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 72 0.1346
27 LYMPHANGIOLEIOMYOMATOSIS 14 0.1284
28 PSYCHOGENIC SEIZURE 118 0.1262
29 MYOCLONIC EPILEPSY 188 0.1238
30 TONIC CONVULSION 172 0.1213
31 BENZODIAZEPINE DRUG LEVEL INCREASED 11 0.1158
32 INTELLECTUAL DISABILITY 161 0.1060
33 SELF-DESTRUCTIVE BEHAVIOUR 89 0.1021
34 PNEUMONITIS ASPIRATION 33 0.0965
35 NEUROPROSTHESIS IMPLANTATION 13 0.0935
36 ANTICONVULSANT DRUG LEVEL INCREASED 145 0.0897
37 POSTICTAL PARALYSIS 21 0.0868
38 OROPHARYNGEAL OEDEMA 12 0.0828
39 HIP DYSPLASIA 17 0.0769
40 PARTIAL SEIZURES 396 0.0755
41 CONGENITAL APLASIA 23 0.0740
42 PETIT MAL EPILEPSY 371 0.0726
43 AORTIC VALVE THICKENING 11 0.0683
44 CEREBRAL ARTERY THROMBOSIS 35 0.0681
45 PROPOFOL INFUSION SYNDROME 47 0.0667
46 STATUS EPILEPTICUS 739 0.0654
47 INFANTILE SPASMS 47 0.0650
48 NEUROSURGERY 12 0.0649
49 DRUG-GENETIC INTERACTION 23 0.0644
50 BRAIN SCAN ABNORMAL 35 0.0627
51 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 40 0.0615
52 DROP ATTACKS 36 0.0606
53 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 23 0.0605
54 FOCAL DYSCOGNITIVE SEIZURES 67 0.0588
55 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 27 0.0577
56 CHOLESTASIS OF PREGNANCY 26 0.0565
57 ANGIOMYOLIPOMA 12 0.0561
58 AUTOMATISM 12 0.0556
59 MITRAL VALVE THICKENING 16 0.0537
60 PRODUCT ADMINISTRATION ISSUE 11 0.0526
61 BEHAVIOUR DISORDER 277 0.0512
62 BLOOD GASES ABNORMAL 27 0.0501
63 PANCREAS INFECTION 20 0.0498
64 MACROGLOSSIA 26 0.0473
65 GENERALISED TONIC-CLONIC SEIZURE 778 0.0470
66 SEIZURE 5161 0.0446
67 PLEOCYTOSIS 23 0.0395
68 TEMPORAL LOBE EPILEPSY 17 0.0389
69 FANCONI SYNDROME 55 0.0389
70 SPINA BIFIDA 80 0.0384
71 BODY DYSMORPHIC DISORDER 14 0.0373
72 CEREBELLAR ATROPHY 32 0.0363
73 CONGENITAL HYDRONEPHROSIS 25 0.0350
74 FOETAL MALFORMATION 38 0.0350
75 CLONIC CONVULSION 25 0.0342
76 RIGHT VENTRICULAR DILATATION 19 0.0328
77 HEPATOBILIARY DISEASE 20 0.0319
78 HYPERAMMONAEMIC ENCEPHALOPATHY 55 0.0316
79 HYPERAMMONAEMIA 157 0.0314
80 MONOCYTOSIS 19 0.0306
81 PARADOXICAL DRUG REACTION 112 0.0304
82 ACIDOSIS HYPERCHLORAEMIC 18 0.0303
83 PULMONARY VALVE INCOMPETENCE 44 0.0301
84 PLAGIOCEPHALY 15 0.0301
85 ANAL ATRESIA 16 0.0300
86 WRONG PATIENT 15 0.0299
87 EXCESSIVE EYE BLINKING 44 0.0297
88 ATAXIA 346 0.0291
89 EPILEPSY 870 0.0284
90 MACROCEPHALY 11 0.0284
91 METAPNEUMOVIRUS INFECTION 22 0.0281
92 FEBRILE CONVULSION 34 0.0279
93 BRAIN OPERATION 63 0.0276
94 AURA 51 0.0273
95 GAZE PALSY 46 0.0270
96 CRYPTORCHISM 30 0.0267
97 TRACHEO-OESOPHAGEAL FISTULA 17 0.0266
98 SELECTIVE EATING DISORDER 24 0.0264
99 INTENTION TREMOR 15 0.0264
100 SEDATION COMPLICATION 67 0.0262
101 PRODUCT PREPARATION ISSUE 170 0.0259
102 SEXUALLY INAPPROPRIATE BEHAVIOUR 12 0.0258
103 SYSTOLIC DYSFUNCTION 27 0.0256
104 BLOOD OESTROGEN INCREASED 15 0.0255
105 DEVELOPMENTAL HIP DYSPLASIA 21 0.0252
106 HEMIANOPIA 25 0.0252
107 SIMPLE PARTIAL SEIZURES 20 0.0248
108 ELECTROENCEPHALOGRAM ABNORMAL 78 0.0247
109 BLINDNESS CORTICAL 12 0.0245
110 HYPOSPADIAS 50 0.0240
111 ENTEROVIRUS INFECTION 20 0.0231
112 JUVENILE IDIOPATHIC ARTHRITIS 56 0.0229
113 LABELLED DRUG-DRUG INTERACTION ISSUE 33 0.0228
114 GASTROSTOMY 35 0.0226
115 RHINOVIRUS INFECTION 86 0.0221
116 ACCIDENTAL POISONING 30 0.0219
117 FOOD REFUSAL 19 0.0217
118 COMPLEX PARTIAL SEIZURES 24 0.0216
119 DROOLING 149 0.0215
120 PYLORIC STENOSIS 18 0.0213
121 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 16 0.0212
122 HEAD BANGING 12 0.0211
123 OTITIS MEDIA ACUTE 15 0.0204
124 ECHOCARDIOGRAM ABNORMAL 28 0.0200
125 NEUROPSYCHOLOGICAL SYMPTOMS 12 0.0199
126 CIRCADIAN RHYTHM SLEEP DISORDER 16 0.0193
127 GENE MUTATION 38 0.0192
128 MOTOR DEVELOPMENTAL DELAY 11 0.0190
129 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 12 0.0185
130 DEVELOPMENTAL DELAY 165 0.0183
131 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 14 0.0179
132 GLIOBLASTOMA MULTIFORME 15 0.0178
133 FOETAL ANTICONVULSANT SYNDROME 21 0.0177
134 LANGUAGE DISORDER 38 0.0176
135 ABDOMINAL COMPARTMENT SYNDROME 11 0.0173
136 RESPIRATORY DISORDER NEONATAL 28 0.0173
137 DEATH NEONATAL 24 0.0172
138 PSYCHOMOTOR SKILLS IMPAIRED 45 0.0172
139 RESPIRATORY DEPRESSION 210 0.0171
140 ANTICONVULSANT DRUG LEVEL DECREASED 24 0.0170
141 STEREOTYPY 16 0.0170
142 RENAL TUBULAR ACIDOSIS 37 0.0169
143 BRADYCARDIA NEONATAL 21 0.0167
144 SEDATION 417 0.0159
145 GINGIVAL HYPERTROPHY 24 0.0158
146 TRACHEITIS 12 0.0157
147 AREFLEXIA 42 0.0157
148 KETOSIS 17 0.0157
149 NYSTAGMUS 82 0.0154
150 POSTICTAL STATE 16 0.0154
151 DRUG RESISTANCE 395 0.0154
152 AORTIC DILATATION 17 0.0153
153 ASTERIXIS 16 0.0150
154 INDIFFERENCE 11 0.0146
155 CLEFT PALATE 28 0.0145
156 AGGRESSION 717 0.0143
157 CLEFT LIP AND PALATE 16 0.0143
158 MOANING 16 0.0141
159 DYSMORPHISM 33 0.0140
160 AMMONIA INCREASED 71 0.0139
161 INAPPROPRIATE AFFECT 22 0.0139
162 BEZOAR 19 0.0138
163 TRICUSPID VALVE INCOMPETENCE 109 0.0137
164 BRADYPNOEA 37 0.0137
165 WRONG PATIENT RECEIVED PRODUCT 40 0.0137
166 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 35 0.0131
167 STARING 31 0.0128
168 CEREBELLAR SYNDROME 28 0.0128
169 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 14 0.0127
170 ARNOLD-CHIARI MALFORMATION 12 0.0126
171 HYPOTONIA 125 0.0125
172 COMA SCALE ABNORMAL 36 0.0124
173 MOTOR DYSFUNCTION 125 0.0123
174 CEREBRAL ATROPHY 48 0.0120
175 PRODUCT ADMINISTRATION INTERRUPTED 94 0.0120
176 DRUG LEVEL INCREASED 195 0.0118
177 MYOCLONUS 140 0.0117
178 LOGORRHOEA 41 0.0116
179 DRUG SCREEN FALSE POSITIVE 32 0.0116
180 ENCEPHALOPATHY 282 0.0115
181 ENCEPHALITIS AUTOIMMUNE 15 0.0114
182 MITRAL VALVE PROLAPSE 19 0.0114
183 PSYCHOMOTOR RETARDATION 32 0.0114
184 POSTURE ABNORMAL 37 0.0114
185 STENOSIS 21 0.0112
186 HYPOTONIA NEONATAL 17 0.0109
187 DROWNING 11 0.0109
188 CHOLECYSTITIS INFECTIVE 30 0.0108
189 LEARNING DISORDER 26 0.0108
190 TONIC CLONIC MOVEMENTS 14 0.0108
191 CLUMSINESS 29 0.0106
192 PARAINFLUENZAE VIRUS INFECTION 16 0.0105
193 HYPERSOMNIA 300 0.0105
194 HYPOVENTILATION 34 0.0104
195 GASTROINTESTINAL TUBE INSERTION 26 0.0104
196 MUSCLE CONTRACTURE 21 0.0103
197 NEUROMYOPATHY 11 0.0103
198 SLOW SPEECH 25 0.0103
199 ABNORMAL BEHAVIOUR 407 0.0103
200 QUADRIPARESIS 17 0.0102
201 MICROCEPHALY 13 0.0101
202 PRODUCT SUPPLY ISSUE 72 0.0101
203 SLEEP DEFICIT 21 0.0099
204 SOMNOLENCE 1995 0.0099
205 SCREAMING 63 0.0099
206 BLOOD LACTIC ACID INCREASED 51 0.0097
207 POLYDACTYLY 11 0.0095
208 OBSESSIVE THOUGHTS 17 0.0094
209 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 48 0.0094
210 PNEUMONIA ASPIRATION 230 0.0092
211 SALIVARY HYPERSECRETION 92 0.0092
212 AKINESIA 19 0.0092
213 FANCONI SYNDROME ACQUIRED 16 0.0091
214 HEPATIC CYTOLYSIS 112 0.0088
215 APRAXIA 13 0.0088
216 THROMBOCYTOSIS 32 0.0087
217 GALLBLADDER INJURY 17 0.0087
218 HEAD TITUBATION 12 0.0087
219 SKULL FRACTURE 14 0.0086
220 DRUG TITRATION ERROR 22 0.0085
221 CONVULSION 485 0.0085
222 HAEMANGIOMA 19 0.0082
223 COGNITIVE DISORDER 379 0.0081
224 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 207 0.0080
225 METABOLIC ENCEPHALOPATHY 24 0.0080
226 AORTIC VALVE INCOMPETENCE 34 0.0080
227 BRUXISM 43 0.0080
228 SUICIDAL BEHAVIOUR 33 0.0079
229 IMPULSIVE BEHAVIOUR 29 0.0077
230 PORPHYRIA ACUTE 11 0.0077
231 HYPERCAPNIA 23 0.0076
232 HYPOTHERMIA 77 0.0076
233 DRUG INTERACTION 1202 0.0076
234 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 46 0.0076
235 DERMATITIS EXFOLIATIVE GENERALISED 26 0.0075
236 PSYCHOMOTOR HYPERACTIVITY 124 0.0075
237 DRUG LEVEL DECREASED 76 0.0075
238 ALTERED STATE OF CONSCIOUSNESS 160 0.0074
239 ASPIRATION 80 0.0073
240 RASH MORBILLIFORM 20 0.0072
241 VENTRICULAR SEPTAL DEFECT 41 0.0072
242 ENDOTRACHEAL INTUBATION 20 0.0071
243 FEELING DRUNK 53 0.0071
244 ACUTE PULMONARY OEDEMA 40 0.0071
245 BRONCHIOLITIS 25 0.0071
246 AUTISM SPECTRUM DISORDER 39 0.0071
247 COMMUNICATION DISORDER 27 0.0071
248 INCREASED BRONCHIAL SECRETION 18 0.0070
249 ATRIAL SEPTAL DEFECT 58 0.0069
250 MITRAL VALVE INCOMPETENCE 78 0.0069
251 DISINHIBITION 11 0.0068
252 EXPOSURE VIA BREAST MILK 27 0.0068
253 HEMIPLEGIA 56 0.0067
254 GRAND MAL CONVULSION 62 0.0067
255 BICYTOPENIA 13 0.0066
256 LICHENOID KERATOSIS 15 0.0066
257 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 49 0.0065
258 REACTION TO EXCIPIENT 15 0.0065
259 ANTINUCLEAR ANTIBODY POSITIVE 21 0.0065
260 ENURESIS 26 0.0064
261 FOETAL EXPOSURE DURING PREGNANCY 523 0.0064
262 LOW BIRTH WEIGHT BABY 51 0.0064
263 RESPIRATORY RATE DECREASED 20 0.0064
264 AFFECTIVE DISORDER 50 0.0064
265 IRRITABILITY 382 0.0063
266 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 21 0.0063
267 HYPOPNOEA 22 0.0063
268 TONGUE BITING 13 0.0063
269 CALCINOSIS 14 0.0063
270 EMERGENCY CARE 19 0.0063
271 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 14 0.0063
272 TYPE IV HYPERSENSITIVITY REACTION 17 0.0062
273 CONVERSION DISORDER 12 0.0062
274 ATROPHY 12 0.0062
275 EYE MOVEMENT DISORDER 42 0.0061
276 BRADYPHRENIA 40 0.0061
277 HYPERPHOSPHATAEMIA 13 0.0060
278 SOCIAL PROBLEM 25 0.0060
279 APNOEA 47 0.0060
280 DYSTONIA 115 0.0059
281 LOOSE TOOTH 19 0.0059
282 PRESCRIBED OVERDOSE 113 0.0058
283 PRODUCT PRESCRIBING ERROR 139 0.0058
284 PULSE ABNORMAL 14 0.0058
285 CORONARY ARTERY STENOSIS 29 0.0058
286 PERSONALITY CHANGE 53 0.0057
287 READING DISORDER 13 0.0057
288 HYDROCEPHALUS 31 0.0057
289 DYSARTHRIA 213 0.0057
290 ANAEMIA MACROCYTIC 12 0.0056
291 DRUG LEVEL BELOW THERAPEUTIC 31 0.0056
292 DEPRESSED LEVEL OF CONSCIOUSNESS 222 0.0056
293 FACIAL BONES FRACTURE 20 0.0055
294 ATRIOVENTRICULAR BLOCK FIRST DEGREE 24 0.0055
295 LETHARGY 317 0.0055
296 PRIAPISM 19 0.0055
297 CLONUS 15 0.0055
298 RESPIRATORY SYNCYTIAL VIRUS INFECTION 47 0.0054
299 HEART DISEASE CONGENITAL 19 0.0054
300 CATATONIA 28 0.0053
301 MOOD ALTERED 145 0.0053
302 STEVENS-JOHNSON SYNDROME 118 0.0053
303 AGITATION 387 0.0053
304 SPEECH DISORDER DEVELOPMENTAL 15 0.0052
305 BUNDLE BRANCH BLOCK RIGHT 24 0.0052
306 HYPERKINESIA 11 0.0052
307 NEUROLOGICAL DECOMPENSATION 12 0.0052
308 SPEECH DISORDER 271 0.0052
309 COORDINATION ABNORMAL 72 0.0052
310 OLIGURIA 32 0.0051
311 AUTONOMIC NERVOUS SYSTEM IMBALANCE 15 0.0051
312 RESPIRATORY DISTRESS 140 0.0051
313 ENCEPHALITIS 35 0.0051
314 PATENT DUCTUS ARTERIOSUS 20 0.0050
315 ANGER 168 0.0050
316 MATERNAL DRUGS AFFECTING FOETUS 38 0.0050
317 PREMATURE BABY 149 0.0049
318 FACIAL PARALYSIS 42 0.0049
319 PSYCHOTIC DISORDER 144 0.0049
320 NECROSIS 27 0.0048
321 APHASIA 146 0.0048
322 HYPERNATRAEMIA 24 0.0048
323 URINARY RETENTION 160 0.0048
324 MOOD SWINGS 152 0.0048
325 STRABISMUS 14 0.0048
326 INTENTIONAL SELF-INJURY 96 0.0047
327 TOXIC EPIDERMAL NECROLYSIS 71 0.0047
328 VENTRICULAR HYPOKINESIA 15 0.0047
329 LIVE BIRTH 39 0.0047
330 PREMATURE LABOUR 26 0.0046
331 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 252 0.0046
332 DYSPHEMIA 20 0.0046
333 ATTENTION DEFICIT HYPERACTIVITY DISORDER 19 0.0045
334 TALIPES 14 0.0045
335 DIPLOPIA 117 0.0045
336 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 46 0.0045
337 HEPATITIS ACUTE 29 0.0045
338 WEIGHT BEARING DIFFICULTY 12 0.0045
339 FOETAL GROWTH RESTRICTION 27 0.0044
340 SUBSTANCE USE DISORDER 14 0.0044
341 INTENTIONAL UNDERDOSE 32 0.0044
342 SOCIAL AVOIDANT BEHAVIOUR 25 0.0043
343 METABOLIC ACIDOSIS 138 0.0043
344 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 14 0.0043
345 THERAPY PARTIAL RESPONDER 67 0.0043
346 HEPATOSPLENOMEGALY 11 0.0043
347 THROMBOPHLEBITIS 15 0.0043
348 HYDRONEPHROSIS 32 0.0043
349 SNORING 16 0.0042
350 COMA 201 0.0042
351 FACE INJURY 16 0.0042
352 NEUTROPENIC SEPSIS 30 0.0042
353 PSYCHIATRIC SYMPTOM 31 0.0042
354 SCOLIOSIS 26 0.0042
355 HYPERTRANSAMINASAEMIA 29 0.0042
356 TOXIC ENCEPHALOPATHY 21 0.0041
357 STILLBIRTH 20 0.0041
358 EXPOSURE DURING PREGNANCY 256 0.0041
359 NEGATIVE THOUGHTS 12 0.0041
360 MATERNAL EXPOSURE DURING PREGNANCY 365 0.0041
361 OBESITY 65 0.0041
362 PNEUMONIA VIRAL 13 0.0041
363 CEREBRAL DISORDER 30 0.0041
364 HALLUCINATIONS, MIXED 17 0.0040
365 TENDERNESS 42 0.0040
366 PRODUCT DISPENSING ISSUE 17 0.0040
367 PREMATURE DELIVERY 63 0.0040
368 MASTICATION DISORDER 12 0.0039
369 DISTURBANCE IN ATTENTION 211 0.0039
370 POTENTIATING DRUG INTERACTION 13 0.0039
371 ABORTION SPONTANEOUS 154 0.0038
372 MYOCARDITIS 44 0.0038
373 INTESTINAL ISCHAEMIA 21 0.0038
374 MATERNAL EXPOSURE BEFORE PREGNANCY 26 0.0038
375 ADENOVIRUS INFECTION 11 0.0038
376 BRAIN INJURY 38 0.0038
377 EOSINOPHILIA 66 0.0038
378 CYANOSIS 59 0.0037
379 DRUG LEVEL ABOVE THERAPEUTIC 17 0.0037
380 NEONATAL RESPIRATORY DISTRESS SYNDROME 13 0.0037
381 BALANCE DISORDER 317 0.0037
382 AFFECT LABILITY 35 0.0036
383 APATHY 53 0.0036
384 ASPHYXIA 29 0.0035
385 SLEEP DISORDER 250 0.0035
386 HYPERTONIA 20 0.0035
387 HALLUCINATION, VISUAL 72 0.0034
388 HYPERTHERMIA 26 0.0034
389 JOINT DISLOCATION 36 0.0034
390 TREATMENT FAILURE 280 0.0034
391 PRODUCT DISTRIBUTION ISSUE 31 0.0033
392 PHARYNGITIS STREPTOCOCCAL 36 0.0033
393 GASTROENTERITIS VIRAL 60 0.0033
394 INTENTIONAL OVERDOSE 213 0.0033
395 INCREASED UPPER AIRWAY SECRETION 17 0.0033
396 CRYING 117 0.0032
397 MATERNAL EXPOSURE DURING BREAST FEEDING 13 0.0032
398 THERAPY NON-RESPONDER 143 0.0032
399 HYPERURICAEMIA 13 0.0032
400 EATING DISORDER 67 0.0031
401 CARDIOTOXICITY 28 0.0031
402 NORMAL NEWBORN 17 0.0031
403 HYPONATRAEMIA 175 0.0031
404 SELF-INJURIOUS IDEATION 13 0.0031
405 HEAD INJURY 98 0.0031
406 DRUG USE DISORDER 26 0.0031
407 PRODUCT CONTAMINATION 11 0.0031
408 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 27 0.0031
409 DYSKINESIA 123 0.0030
410 TOXICITY TO VARIOUS AGENTS 510 0.0030
411 HAEMODYNAMIC INSTABILITY 23 0.0030
412 ACUTE RESPIRATORY FAILURE 58 0.0030
413 LIPASE INCREASED 23 0.0030
414 MUSCLE TWITCHING 69 0.0030
415 MIOSIS 24 0.0030
416 BLOOD CREATINE PHOSPHOKINASE INCREASED 86 0.0030
417 SLEEP APNOEA SYNDROME 57 0.0030
418 CONGENITAL ANOMALY 23 0.0030
419 MYDRIASIS 38 0.0030
420 HOSPITALISATION 455 0.0030
421 HYPERACUSIS 11 0.0030
422 PREGNANCY 59 0.0029
423 VIRAL UPPER RESPIRATORY TRACT INFECTION 14 0.0029
424 UNRESPONSIVE TO STIMULI 76 0.0029
425 CAESAREAN SECTION 34 0.0029
426 DECREASED APPETITE 673 0.0029
427 PRODUCT USE IN UNAPPROVED INDICATION 717 0.0029
428 DIARRHOEA HAEMORRHAGIC 27 0.0029
429 TUBULOINTERSTITIAL NEPHRITIS 54 0.0029
430 ACIDOSIS 22 0.0029
431 NEUROLEPTIC MALIGNANT SYNDROME 34 0.0029
432 CONDITION AGGRAVATED 859 0.0028
433 RESPIRATORY FAILURE 205 0.0028
434 EAR INFECTION 74 0.0028
435 VIRAL INFECTION 92 0.0028
436 HYPERPHAGIA 11 0.0028
437 GAMMA-GLUTAMYLTRANSFERASE INCREASED 61 0.0027
438 PRODUCT USE ISSUE 515 0.0027
439 DYSGRAPHIA 18 0.0027
440 SUICIDE ATTEMPT 165 0.0027
441 APPETITE DISORDER 18 0.0027
442 HALLUCINATION, AUDITORY 43 0.0027
443 SHOCK 62 0.0027
444 POOR QUALITY SLEEP 58 0.0027
445 BRAIN OEDEMA 34 0.0027
446 ATELECTASIS 26 0.0027
447 OFF LABEL USE 2351 0.0027
448 FEEDING DISORDER 54 0.0027
449 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 19 0.0026
450 CIRCULATORY COLLAPSE 45 0.0026
451 BODY TEMPERATURE DECREASED 26 0.0026
452 CARDIOMYOPATHY 39 0.0026
453 URINE OUTPUT DECREASED 23 0.0026
454 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 45 0.0026
455 OBSESSIVE-COMPULSIVE DISORDER 21 0.0026
456 INCREASED APPETITE 50 0.0026
457 HYPOGAMMAGLOBULINAEMIA 17 0.0026
458 ATRIOVENTRICULAR BLOCK 20 0.0026
459 RESPIRATORY DISORDER 77 0.0026
460 PARKINSONISM 25 0.0026
461 HEPATIC FAILURE 77 0.0026
462 CHOLESTASIS 49 0.0025
463 DRUG INEFFECTIVE 3361 0.0025
464 SKIN ABRASION 12 0.0025
465 EMOTIONAL DISORDER 78 0.0025
466 MANIA 41 0.0025
467 VISUAL FIELD DEFECT 18 0.0025
468 THROMBOCYTOPENIA 277 0.0025
469 MENTAL IMPAIRMENT 60 0.0025
470 PRODUCT AVAILABILITY ISSUE 56 0.0025
471 INTENTIONAL PRODUCT MISUSE 215 0.0025
472 GAIT INABILITY 82 0.0025
473 LEARNING DISABILITY 13 0.0024
474 RASH MACULO-PAPULAR 54 0.0024
475 HEMIPARESIS 41 0.0024
476 SMALL FOR DATES BABY 12 0.0024
477 RESTLESSNESS 88 0.0024
478 HIP SURGERY 13 0.0024
479 SINUS BRADYCARDIA 23 0.0024
480 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 169 0.0024
481 INCONTINENCE 25 0.0024
482 URINARY INCONTINENCE 70 0.0024
483 WITHDRAWAL SYNDROME 99 0.0024
484 SLUGGISHNESS 24 0.0024
485 HYPOPHAGIA 60 0.0023
486 FAECES SOFT 17 0.0023
487 GAIT DISTURBANCE 447 0.0023
488 DEPRESSED MOOD 123 0.0023
489 BIPOLAR DISORDER 25 0.0023
490 OXYGEN SATURATION DECREASED 129 0.0023
491 INSURANCE ISSUE 35 0.0023
492 TOXIC SKIN ERUPTION 23 0.0023
493 PARANOIA 39 0.0023
494 PRODUCT DOSE OMISSION 147 0.0022
495 ELECTROCARDIOGRAM QT PROLONGED 81 0.0022
496 SEROTONIN SYNDROME 43 0.0022
497 ABORTION INDUCED 21 0.0022
498 PNEUMONIA 720 0.0022
499 PRODUCT CONTAINER ISSUE 19 0.0022
500 ENERGY INCREASED 13 0.0022
501 BRADYKINESIA 13 0.0022
502 HEPATIC STEATOSIS 41 0.0022
503 LIQUID PRODUCT PHYSICAL ISSUE 16 0.0022
504 BRADYCARDIA 116 0.0022
505 TREMOR 363 0.0022
506 BRAIN NEOPLASM 20 0.0022
507 RESPIRATION ABNORMAL 15 0.0022
508 PRODUCT DOSE OMISSION ISSUE 639 0.0022
509 HYPERPROLACTINAEMIA 14 0.0022
510 PRODUCT PRESCRIBING ISSUE 47 0.0022
511 CARDIAC ARREST 178 0.0022
512 CHOKING 42 0.0022
513 CONFUSIONAL STATE 346 0.0021
514 RESPIRATORY ARREST 59 0.0021
515 RESPIRATORY RATE INCREASED 19 0.0021
516 HYPOXIA 75 0.0021
517 TRANSAMINASES INCREASED 47 0.0021
518 HEPATOTOXICITY 47 0.0021
519 MEMORY IMPAIRMENT 289 0.0021
520 DRUG ABUSE 175 0.0021
521 PHARYNGITIS 26 0.0021
522 PRODUCT USE COMPLAINT 33 0.0021
523 MULTIPLE ORGAN DYSFUNCTION SYNDROME 59 0.0021
524 FALL 693 0.0021
525 DELIRIUM 72 0.0021
526 ISCHAEMIC STROKE 37 0.0021
527 PNEUMONIA BACTERIAL 19 0.0021
528 POISONING 26 0.0021
529 OBSTRUCTIVE AIRWAYS DISORDER 23 0.0021
530 METABOLIC DISORDER 12 0.0021
531 DYSSTASIA 60 0.0021
532 MAJOR DEPRESSION 15 0.0021
533 EUPHORIC MOOD 21 0.0020
534 INITIAL INSOMNIA 21 0.0020
535 POISONING DELIBERATE 19 0.0020
536 RESPIRATORY TRACT INFECTION 52 0.0020
537 PSEUDOMONAS INFECTION 17 0.0020
538 PRODUCT SUBSTITUTION ISSUE 114 0.0020
539 DRUG ERUPTION 35 0.0020
540 THERMAL BURN 14 0.0020
541 DISORIENTATION 78 0.0020
542 LEUKOCYTOSIS 35 0.0019
543 MUSCLE RIGIDITY 23 0.0019
544 AMNESIA 125 0.0019
545 LEUKOPENIA 96 0.0019
546 MENTAL STATUS CHANGES 53 0.0019
547 MOUTH SWELLING 11 0.0019
548 OVERDOSE 411 0.0019
549 HEPATOCELLULAR INJURY 27 0.0019
550 THIRST 34 0.0019
551 SUICIDAL IDEATION 174 0.0019
552 HAEMOLYTIC ANAEMIA 17 0.0019
553 DISEASE RECURRENCE 90 0.0019
554 ANAL INCONTINENCE 17 0.0019
555 HEPATIC ENZYME INCREASED 128 0.0019
556 MALNUTRITION 21 0.0019
557 RETCHING 40 0.0019
558 DYSPHAGIA 178 0.0019
559 MIDDLE INSOMNIA 35 0.0019
560 PANCREATITIS ACUTE 42 0.0019
561 DECREASED INTEREST 11 0.0019
562 LIVER FUNCTION TEST INCREASED 40 0.0019
563 HYPOKINESIA 27 0.0019
564 FRUSTRATION TOLERANCE DECREASED 15 0.0019
565 BRAIN FOG 29 0.0018
566 PRODUCT TASTE ABNORMAL 25 0.0018
567 ODYNOPHAGIA 11 0.0018
568 DECUBITUS ULCER 15 0.0018
569 INSOMNIA 489 0.0018
570 HAND FRACTURE 13 0.0018
571 LACERATION 17 0.0018
572 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 14 0.0018
573 PANCREATITIS 95 0.0018
574 LEFT VENTRICULAR DYSFUNCTION 12 0.0018
575 POST-TRAUMATIC STRESS DISORDER 12 0.0018
576 DRUG-INDUCED LIVER INJURY 56 0.0018
577 WRONG PRODUCT ADMINISTERED 12 0.0018
578 PERICARDIAL EFFUSION 41 0.0018
579 BLOOD ALBUMIN DECREASED 14 0.0018
580 WEIGHT DECREASED 492 0.0018
581 ALANINE AMINOTRANSFERASE INCREASED 108 0.0018
582 SECRETION DISCHARGE 22 0.0018
583 BLOOD SODIUM DECREASED 33 0.0017
584 DERMATITIS ALLERGIC 22 0.0017
585 PYREXIA 598 0.0017
586 ERECTILE DYSFUNCTION 44 0.0017
587 MOVEMENT DISORDER 55 0.0017
588 HICCUPS 14 0.0017
589 WEIGHT INCREASED 381 0.0017
590 ARRHYTHMIA 80 0.0017
591 SENSORY DISTURBANCE 27 0.0017
592 CONCUSSION 13 0.0017
593 PERIPHERAL COLDNESS 23 0.0017
594 LIVER INJURY 41 0.0017
595 URINARY TRACT INFECTION 284 0.0017
596 ATRIOVENTRICULAR BLOCK COMPLETE 11 0.0016
597 HYPERBILIRUBINAEMIA 17 0.0016
598 BLOOD LACTATE DEHYDROGENASE INCREASED 26 0.0016
599 VENTRICULAR EXTRASYSTOLES 17 0.0016
600 GINGIVAL PAIN 13 0.0016
601 SWOLLEN TONGUE 51 0.0016
602 DRUG EXPOSURE DURING PREGNANCY 55 0.0016
603 DRUG INTOLERANCE 156 0.0016
604 INTENTIONAL DOSE OMISSION 46 0.0016
605 SYNOVITIS 29 0.0016
606 SKIN INFECTION 18 0.0016
607 NEPHROPATHY TOXIC 18 0.0016
608 PURPURA 14 0.0016
609 DECREASED ACTIVITY 17 0.0016
610 SKIN LACERATION 17 0.0016
611 COAGULOPATHY 26 0.0016
612 CARDIO-RESPIRATORY ARREST 65 0.0016
613 PRESCRIBED UNDERDOSE 31 0.0016
614 ASPARTATE AMINOTRANSFERASE INCREASED 82 0.0015
615 ACCIDENTAL OVERDOSE 56 0.0015
616 ACUTE RESPIRATORY DISTRESS SYNDROME 27 0.0015
617 HEPATOMEGALY 15 0.0015
618 THERAPY CHANGE 15 0.0015
619 HEPATITIS 39 0.0015
620 JAUNDICE 41 0.0015
621 POOR QUALITY PRODUCT ADMINISTERED 16 0.0015
622 FATIGUE 1182 0.0015
623 VENTRICULAR TACHYCARDIA 25 0.0015
624 HEART RATE DECREASED 53 0.0015
625 REBOUND EFFECT 17 0.0015
626 NEPHROLITHIASIS 69 0.0015
627 ERYTHEMA MULTIFORME 14 0.0015
628 THERAPEUTIC RESPONSE UNEXPECTED 67 0.0015
629 RHABDOMYOLYSIS 62 0.0015
630 SCHIZOPHRENIA 18 0.0015
631 SINUS TACHYCARDIA 21 0.0015
632 HEPATIC FUNCTION ABNORMAL 55 0.0015
633 CLOSTRIDIUM DIFFICILE INFECTION 32 0.0015
634 MUSCLE SPASTICITY 18 0.0015
635 HYPOKALAEMIA 67 0.0015
636 BLOOD ALKALINE PHOSPHATASE INCREASED 36 0.0014
637 LUPUS-LIKE SYNDROME 13 0.0014
638 HALLUCINATION 108 0.0014
639 NEUROTOXICITY 25 0.0014
640 DRUG DEPENDENCE 229 0.0014
641 CONSTIPATION 310 0.0014
642 POLYNEUROPATHY 17 0.0014
643 LIGAMENT SPRAIN 14 0.0014
644 SURGERY 83 0.0014
645 SEASONAL ALLERGY 20 0.0014
646 LOSS OF CONSCIOUSNESS 180 0.0014
647 SEPTIC SHOCK 61 0.0014
648 HYPERGLYCAEMIA 51 0.0014
649 INFLUENZA 156 0.0014
650 ANURIA 12 0.0014
651 ACUTE HEPATIC FAILURE 19 0.0014
652 CARDIAC MURMUR 12 0.0014
653 PYELONEPHRITIS 12 0.0014
654 UNDERDOSE 101 0.0014
655 ELECTROLYTE IMBALANCE 16 0.0014
656 GENERALISED OEDEMA 17 0.0014
657 ILLNESS 141 0.0014
658 ILEUS 17 0.0014
659 UPPER RESPIRATORY TRACT INFECTION 63 0.0014
660 LYMPHADENOPATHY 48 0.0014
661 DRUG EFFECT LESS THAN EXPECTED 20 0.0013
662 ADVERSE DRUG REACTION 121 0.0013
663 VOMITING 632 0.0013
664 VITAMIN D DEFICIENCY 13 0.0013
665 TACHYCARDIA 118 0.0013
666 SUBDURAL HAEMATOMA 19 0.0013
667 SUDDEN DEATH 14 0.0013
668 PALLOR 36 0.0013
669 DEHYDRATION 176 0.0013
670 TREATMENT NONCOMPLIANCE 72 0.0013
671 NERVOUS SYSTEM DISORDER 41 0.0013
672 LIVER FUNCTION TEST ABNORMAL 38 0.0013
673 GASTROINTESTINAL DISORDER 117 0.0013
674 OVARIAN CYST 13 0.0013
675 THINKING ABNORMAL 24 0.0013
676 KIDNEY INFECTION 25 0.0013
677 PARALYSIS 18 0.0013
678 SUPRAVENTRICULAR TACHYCARDIA 12 0.0013
679 EXTRAPYRAMIDAL DISORDER 31 0.0012
680 COMPLICATION ASSOCIATED WITH DEVICE 18 0.0012
681 PULMONARY OEDEMA 55 0.0012
682 GASTROINTESTINAL INFECTION 11 0.0012
683 CLOSTRIDIUM DIFFICILE COLITIS 13 0.0012
684 PHOTOPHOBIA 23 0.0012
685 THERAPEUTIC RESPONSE DECREASED 74 0.0012
686 SMALL INTESTINAL OBSTRUCTION 15 0.0012
687 STAPHYLOCOCCAL INFECTION 40 0.0012
688 GENERAL PHYSICAL HEALTH DETERIORATION 140 0.0012
689 INABILITY TO AFFORD MEDICATION 12 0.0012
690 MEDICATION ERROR 67 0.0012
691 DYSURIA 44 0.0012
692 MENTAL DISORDER 52 0.0012
693 OSTEOPENIA 18 0.0012
694 FACE OEDEMA 20 0.0012
695 DRUG DOSE OMISSION 196 0.0012
696 DRUG DISPENSING ERROR 18 0.0012
697 DENTAL CARIES 13 0.0012
698 FOOT DEFORMITY 13 0.0012
699 MUSCLE TIGHTNESS 19 0.0012
700 SEPSIS 130 0.0012
701 EYE DISORDER 38 0.0012
702 DIZZINESS 574 0.0011
703 INTENTIONAL PRODUCT USE ISSUE 100 0.0011
704 PRODUCT ADMINISTRATION ERROR 23 0.0011
705 THERAPY INTERRUPTED 81 0.0011
706 HYPOTENSION 227 0.0011
707 AGRANULOCYTOSIS 21 0.0011
708 SPLENOMEGALY 13 0.0011
709 DEVICE RELATED INFECTION 17 0.0011
710 VERTIGO 67 0.0011
711 BLISTER 61 0.0011
712 ANXIETY 307 0.0011
713 MUSCULAR WEAKNESS 122 0.0011
714 BACTERIAL INFECTION 20 0.0011
715 SKIN DISCOLOURATION 49 0.0011
716 BEDRIDDEN 14 0.0011
717 PRODUCT DISPENSING ERROR 23 0.0011
718 PETECHIAE 11 0.0011
719 HYPERCALCAEMIA 13 0.0011
720 FUNGAL INFECTION 35 0.0010
721 C-REACTIVE PROTEIN INCREASED 38 0.0010
722 MOUTH ULCERATION 22 0.0010
723 DEPRESSION 235 0.0010
724 JOINT INJURY 22 0.0010
725 BODY TEMPERATURE INCREASED 21 0.0010
726 SKIN FISSURES 20 0.0010
727 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 49 0.0010
728 CENTRAL NERVOUS SYSTEM LESION 14 0.0010
729 PNEUMOTHORAX 16 0.0010
730 RASH 439 0.0010
731 FOOT FRACTURE 19 0.0010
732 DIARRHOEA 646 0.0010
733 GASTROINTESTINAL PAIN 11 0.0010
734 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 202 0.0010
735 SOPOR 13 0.0010
736 ADVERSE EVENT 90 0.0010
737 IMPAIRED QUALITY OF LIFE 14 0.0010
738 COMPLETED SUICIDE 81 0.0010
739 HYPOTHYROIDISM 31 0.0010
740 CONJUNCTIVITIS 18 0.0010
741 SWELLING FACE 63 0.0010
742 COLD SWEAT 17 0.0010
743 WHITE BLOOD CELL COUNT INCREASED 37 0.0010
744 LIP SWELLING 32 0.0010
745 PANIC ATTACK 35 0.0010
746 AKATHISIA 13 0.0010
747 VISUAL IMPAIRMENT 118 0.0010
748 DRUG WITHDRAWAL SYNDROME NEONATAL 14 0.0009
749 POST PROCEDURAL COMPLICATION 18 0.0009
750 HERNIA 18 0.0009
751 ABASIA 23 0.0009
752 RIB FRACTURE 19 0.0009
753 DISSEMINATED INTRAVASCULAR COAGULATION 13 0.0009
754 NASOPHARYNGITIS 170 0.0009
755 PANCYTOPENIA 51 0.0009
756 SARS-COV-2 TEST POSITIVE 12 0.0009
757 MOBILITY DECREASED 65 0.0009
758 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 163 0.0009
759 NO THERAPEUTIC RESPONSE 11 0.0009
760 DELUSION 14 0.0009
761 SPINAL FRACTURE 18 0.0009
762 FRACTURE 17 0.0009
763 FEELING JITTERY 17 0.0009
764 CYST 11 0.0009
765 BLINDNESS 36 0.0009
766 DRUG TOXICITY 12 0.0009
767 BRONCHITIS 65 0.0009
768 CONTUSION 84 0.0009
769 PULMONARY HYPERTENSION 18 0.0009
770 RASH ERYTHEMATOUS 41 0.0009
771 BLOOD TEST ABNORMAL 12 0.0009
772 INFLAMMATION 44 0.0009
773 INFECTION 122 0.0008
774 CYTOMEGALOVIRUS INFECTION 14 0.0008
775 NERVOUSNESS 44 0.0008
776 CHROMATURIA 19 0.0008
777 SKIN LESION 23 0.0008
778 NIGHTMARE 29 0.0008
779 VISION BLURRED 115 0.0008
780 ROAD TRAFFIC ACCIDENT 35 0.0008
781 PULMONARY CONGESTION 11 0.0008
782 BLOOD PRESSURE FLUCTUATION 20 0.0008
783 HYPERSENSITIVITY 154 0.0008
784 EPISTAXIS 62 0.0008
785 PULMONARY ARTERIAL HYPERTENSION 12 0.0008
786 BLOOD CREATININE INCREASED 54 0.0008
787 COVID-19 145 0.0008
788 THERAPEUTIC PRODUCT EFFECT DECREASED 37 0.0008
789 DRUG EFFECT INCOMPLETE 30 0.0008
790 PRESYNCOPE 20 0.0008
791 PLATELET COUNT DECREASED 87 0.0008
792 THROAT TIGHTNESS 22 0.0008
793 FEELING ABNORMAL 194 0.0008
794 IMPAIRED GASTRIC EMPTYING 11 0.0008
795 NEUTROPENIA 109 0.0008
796 INTESTINAL OBSTRUCTION 30 0.0008
797 HUNGER 11 0.0008
798 PROTEINURIA 15 0.0008
799 ASTHENIA 294 0.0008
800 OSTEOPOROSIS 32 0.0008
801 FEMUR FRACTURE 24 0.0008
802 HEADACHE 485 0.0008
803 LIMB INJURY 21 0.0008
804 ANGIOEDEMA 34 0.0008
805 WHITE BLOOD CELL COUNT DECREASED 83 0.0008
806 ABDOMINAL DISTENSION 79 0.0008
807 GASTROENTERITIS 11 0.0008
808 DISEASE PROGRESSION 89 0.0008
809 SYNCOPE 75 0.0007
810 ACUTE KIDNEY INJURY 114 0.0007
811 FEAR 20 0.0007
812 RHINORRHOEA 48 0.0007
813 OEDEMA 40 0.0007
814 SYSTEMIC LUPUS ERYTHEMATOSUS 26 0.0007
815 NO ADVERSE EVENT 132 0.0007
816 EAR PAIN 14 0.0007
817 FEELING COLD 20 0.0007
818 FEELING HOT 44 0.0007
819 RESTLESS LEGS SYNDROME 13 0.0007
820 SNEEZING 16 0.0007
821 ANKLE FRACTURE 11 0.0007
822 EJECTION FRACTION DECREASED 11 0.0007
823 ALOPECIA 138 0.0007
824 SCAR 12 0.0007
825 INCORRECT DOSE ADMINISTERED 160 0.0007
826 RED BLOOD CELL COUNT DECREASED 20 0.0007
827 NECK PAIN 39 0.0007
828 MUSCULOSKELETAL STIFFNESS 61 0.0007
829 RASH GENERALISED 18 0.0007
830 CELLULITIS 35 0.0007
831 BONE MARROW FAILURE 14 0.0007
832 DISCOMFORT 42 0.0007
833 ABDOMINAL PAIN 160 0.0007
834 HYPOCALCAEMIA 13 0.0007
835 PRODUCT PREPARATION ERROR 14 0.0007
836 DIABETES MELLITUS INADEQUATE CONTROL 12 0.0007
837 LOWER LIMB FRACTURE 13 0.0007
838 HEART RATE INCREASED 67 0.0007
839 UNEVALUABLE EVENT 51 0.0007
840 CARDIAC DISORDER 63 0.0007
841 MUSCLE SPASMS 123 0.0007
842 INTERNATIONAL NORMALISED RATIO INCREASED 19 0.0007
843 THERAPY CESSATION 34 0.0007
844 BLOOD PRESSURE DECREASED 44 0.0007
845 OROPHARYNGEAL PAIN 61 0.0007
846 GASTROOESOPHAGEAL REFLUX DISEASE 53 0.0007
847 DISABILITY 13 0.0007
848 DEAFNESS 17 0.0006
849 PRODUCTIVE COUGH 31 0.0006
850 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 19 0.0006
851 JOINT STIFFNESS 17 0.0006
852 PRODUCT PHYSICAL ISSUE 13 0.0006
853 CEREBRAL HAEMORRHAGE 23 0.0006
854 HAEMATURIA 22 0.0006
855 HYPOGLYCAEMIA 31 0.0006
856 CATARACT 38 0.0006
857 LOWER RESPIRATORY TRACT INFECTION 29 0.0006
858 FREQUENT BOWEL MOVEMENTS 17 0.0006
859 RASH MACULAR 22 0.0006
860 DRY MOUTH 51 0.0006
861 MIGRAINE 60 0.0006
862 ORAL PAIN 14 0.0006
863 RENAL DISORDER 29 0.0006
864 EXTRA DOSE ADMINISTERED 25 0.0006
865 COUGH 173 0.0006
866 OEDEMA PERIPHERAL 75 0.0006
867 GOUT 11 0.0006
868 ILL-DEFINED DISORDER 37 0.0006
869 ANAEMIA 116 0.0006
870 HAEMATOCRIT DECREASED 12 0.0006
871 DEEP VEIN THROMBOSIS 39 0.0006
872 FLATULENCE 34 0.0006
873 NASAL CONGESTION 35 0.0006
874 HAEMATEMESIS 15 0.0006
875 LACTIC ACIDOSIS 19 0.0006
876 ABDOMINAL PAIN UPPER 118 0.0006
877 EXPIRED PRODUCT ADMINISTERED 19 0.0006
878 DEATH 487 0.0006
879 BLOOD PRESSURE SYSTOLIC INCREASED 11 0.0006
880 LACRIMATION INCREASED 17 0.0006
881 NAUSEA 444 0.0006
882 STOMATITIS 34 0.0006
883 RENAL IMPAIRMENT 47 0.0006
884 INTERSTITIAL LUNG DISEASE 27 0.0006
885 SKIN CANCER 12 0.0006
886 SINUSITIS 57 0.0006
887 INJURY 39 0.0006
888 INCORRECT PRODUCT ADMINISTRATION DURATION 12 0.0006
889 MUSCULOSKELETAL PAIN 29 0.0006
890 BLOOD PRESSURE ABNORMAL 11 0.0006
891 LUNG DISORDER 27 0.0006
892 GYNAECOMASTIA 17 0.0005
893 HYPERKALAEMIA 19 0.0005
894 HAEMATOMA 14 0.0005
895 RASH PAPULAR 12 0.0005
896 GASTRITIS 14 0.0005
897 ERYTHEMA 109 0.0005
898 MALAISE 232 0.0005
899 CHOLELITHIASIS 17 0.0005
900 NEOPLASM PROGRESSION 18 0.0005
901 HAEMOGLOBIN DECREASED 53 0.0005
902 URTICARIA 85 0.0005
903 PERIPHERAL SWELLING 78 0.0005
904 WHEEZING 30 0.0005
905 POLLAKIURIA 21 0.0005
906 CYSTITIS 16 0.0005
907 SWELLING 47 0.0005
908 HYPOAESTHESIA 74 0.0005
909 PLEURAL EFFUSION 30 0.0005
910 HEART RATE IRREGULAR 11 0.0005
911 OCULAR HYPERAEMIA 23 0.0005
912 INFUSION RELATED REACTION 32 0.0005
913 ACNE 36 0.0005
914 ABNORMAL DREAMS 13 0.0005
915 DEMENTIA 13 0.0005
916 PULMONARY EMBOLISM 44 0.0005
917 RENAL FAILURE 61 0.0005
918 DIABETIC KETOACIDOSIS 11 0.0005
919 DYSPNOEA 259 0.0005
920 TINNITUS 21 0.0005
921 DRUG WITHDRAWAL SYNDROME 40 0.0005
922 LIVER DISORDER 20 0.0005
923 HYPERHIDROSIS 58 0.0004
924 COLITIS 17 0.0004
925 DYSPEPSIA 44 0.0004
926 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 15 0.0004
927 ABDOMINAL DISCOMFORT 74 0.0004
928 FEBRILE NEUTROPENIA 29 0.0004
929 HAEMOPTYSIS 12 0.0004
930 EYE SWELLING 16 0.0004
931 CEREBROVASCULAR ACCIDENT 72 0.0004
932 RASH PRURITIC 23 0.0004
933 THROAT IRRITATION 19 0.0004
934 HYPERTENSION 89 0.0004
935 NEUTROPHIL COUNT DECREASED 17 0.0004
936 MENSTRUATION IRREGULAR 11 0.0004
937 EYE PAIN 23 0.0004
938 HIP FRACTURE 13 0.0004
939 FLUSHING 41 0.0004
940 SKIN EXFOLIATION 34 0.0004
941 CHILLS 46 0.0004
942 PRODUCT DOSE OMISSION IN ERROR 11 0.0004
943 HAEMATOCHEZIA 21 0.0004
944 ANAPHYLACTIC REACTION 21 0.0004
945 BACK PAIN 85 0.0004
946 CORONARY ARTERY DISEASE 11 0.0004
947 THERAPEUTIC RESPONSE SHORTENED 12 0.0004
948 LIMB DISCOMFORT 11 0.0004
949 BLOOD GLUCOSE DECREASED 17 0.0004
950 PRURITUS 135 0.0004
951 PRODUCT QUALITY ISSUE 47 0.0003
952 ECZEMA 18 0.0003
953 DYSPHONIA 20 0.0003
954 PAIN IN EXTREMITY 100 0.0003
955 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 24 0.0003
956 THROMBOSIS 27 0.0003
957 FLUID RETENTION 17 0.0003
958 DRUG EFFECT DECREASED 18 0.0003
959 BLOOD CHOLESTEROL INCREASED 15 0.0003
960 PARAESTHESIA 50 0.0003
961 PAIN 194 0.0003
962 BLOOD PRESSURE INCREASED 48 0.0003
963 RENAL FAILURE ACUTE 13 0.0003
964 MYELOSUPPRESSION 11 0.0003
965 CHEST PAIN 56 0.0003
966 HYPOACUSIS 13 0.0003
967 ASTHMA 34 0.0003
968 BURNING SENSATION 21 0.0003
969 GASTROINTESTINAL HAEMORRHAGE 25 0.0003
970 ATRIAL FIBRILLATION 29 0.0003
971 INFLUENZA LIKE ILLNESS 24 0.0003
972 PALPITATIONS 34 0.0003
973 OSTEOARTHRITIS 12 0.0003
974 HERPES ZOSTER 16 0.0003
975 EYE IRRITATION 16 0.0003
976 NEUROPATHY PERIPHERAL 26 0.0003
977 DRY SKIN 36 0.0003
978 NEOPLASM MALIGNANT 18 0.0003
979 JOINT SWELLING 32 0.0003
980 ARTHRALGIA 102 0.0002
981 MALIGNANT NEOPLASM PROGRESSION 25 0.0002
982 CARDIAC FAILURE 19 0.0002
983 MYALGIA 40 0.0002
984 HAEMORRHAGE 24 0.0002
985 DRY EYE 11 0.0002
986 MYOCARDIAL INFARCTION 38 0.0002
987 ARTHRITIS 17 0.0002
988 CHEST DISCOMFORT 21 0.0002
989 PRODUCT STORAGE ERROR 16 0.0002
990 DYSGEUSIA 13 0.0002
991 ACCIDENTAL EXPOSURE TO PRODUCT 18 0.0002
992 PSORIASIS 18 0.0001
993 EMOTIONAL DISTRESS 13 0.0001
994 BLOOD GLUCOSE INCREASED 17 0.0001
995 INJECTION SITE PAIN 18 0.0001